nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—hypertension—type 2 diabetes mellitus	0.362	1	CtDrD
Spironolactone—SHBG—type 2 diabetes mellitus	0.089	0.308	CbGaD
Spironolactone—AR—type 2 diabetes mellitus	0.078	0.27	CbGaD
Spironolactone—ABCC2—type 2 diabetes mellitus	0.0694	0.24	CbGaD
Spironolactone—NR3C1—type 2 diabetes mellitus	0.0529	0.183	CbGaD
Spironolactone—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0311	0.15	CbGbCtD
Spironolactone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0193	0.093	CbGbCtD
Spironolactone—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0179	0.0862	CbGbCtD
Spironolactone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0154	0.0744	CbGbCtD
Spironolactone—ABCC2—Glyburide—type 2 diabetes mellitus	0.0148	0.0715	CbGbCtD
Spironolactone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0146	0.0707	CbGbCtD
Spironolactone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0139	0.0673	CbGbCtD
Spironolactone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.013	0.063	CbGbCtD
Spironolactone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0129	0.0621	CbGbCtD
Spironolactone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0124	0.06	CbGbCtD
Spironolactone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0101	0.0489	CbGbCtD
Spironolactone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00943	0.0455	CbGbCtD
Spironolactone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00652	0.0315	CbGbCtD
Spironolactone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00648	0.0313	CbGbCtD
Spironolactone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00483	0.0233	CbGbCtD
Spironolactone—ABCB1—Losartan—type 2 diabetes mellitus	0.00441	0.0213	CbGbCtD
Spironolactone—SHBG—hindlimb—type 2 diabetes mellitus	0.00157	0.114	CbGeAlD
Spironolactone—AR—penis—type 2 diabetes mellitus	0.00149	0.109	CbGeAlD
Spironolactone—PGR—artery—type 2 diabetes mellitus	0.000868	0.0632	CbGeAlD
Spironolactone—CYP11B2—cardiovascular system—type 2 diabetes mellitus	0.000735	0.0535	CbGeAlD
Spironolactone—NR3C1—nerve—type 2 diabetes mellitus	0.000497	0.0362	CbGeAlD
Spironolactone—NR3C2—retina—type 2 diabetes mellitus	0.000384	0.0279	CbGeAlD
Spironolactone—NR3C2—nephron tubule—type 2 diabetes mellitus	0.000361	0.0263	CbGeAlD
Spironolactone—SHBG—cardiovascular system—type 2 diabetes mellitus	0.000335	0.0244	CbGeAlD
Spironolactone—NR3C2—cardiovascular system—type 2 diabetes mellitus	0.000324	0.0236	CbGeAlD
Spironolactone—NR3C2—kidney—type 2 diabetes mellitus	0.000317	0.0231	CbGeAlD
Spironolactone—NR3C2—cortex of kidney—type 2 diabetes mellitus	0.000309	0.0225	CbGeAlD
Spironolactone—PGR—cardiovascular system—type 2 diabetes mellitus	0.000302	0.0219	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.000295	0.117	CrCbGaD
Spironolactone—SHBG—adipose tissue—type 2 diabetes mellitus	0.000295	0.0215	CbGeAlD
Spironolactone—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000288	0.021	CbGeAlD
Spironolactone—NR3C2—adipose tissue—type 2 diabetes mellitus	0.000286	0.0208	CbGeAlD
Spironolactone—SLCO1A2—kidney—type 2 diabetes mellitus	0.000272	0.0198	CbGeAlD
Spironolactone—PGR—adipose tissue—type 2 diabetes mellitus	0.000266	0.0194	CbGeAlD
Spironolactone—ABCC2—kidney—type 2 diabetes mellitus	0.000254	0.0184	CbGeAlD
Spironolactone—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000247	0.018	CbGeAlD
Spironolactone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000241	0.0175	CbGeAlD
Spironolactone—AR—cardiovascular system—type 2 diabetes mellitus	0.00024	0.0175	CbGeAlD
Spironolactone—AR—kidney—type 2 diabetes mellitus	0.000235	0.0171	CbGeAlD
Spironolactone—Oxandrolone—AR—type 2 diabetes mellitus	0.000231	0.0917	CrCbGaD
Spironolactone—AR—cortex of kidney—type 2 diabetes mellitus	0.000229	0.0167	CbGeAlD
Spironolactone—AR—adipose tissue—type 2 diabetes mellitus	0.000212	0.0154	CbGeAlD
Spironolactone—SHBG—liver—type 2 diabetes mellitus	0.000207	0.0151	CbGeAlD
Spironolactone—NR3C2—liver—type 2 diabetes mellitus	0.000201	0.0146	CbGeAlD
Spironolactone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000194	0.0141	CbGeAlD
Spironolactone—CYP2C8—kidney—type 2 diabetes mellitus	0.00019	0.0138	CbGeAlD
Spironolactone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000174	0.0127	CbGeAlD
Spironolactone—SLCO1A2—liver—type 2 diabetes mellitus	0.000172	0.0125	CbGeAlD
Spironolactone—NR3C1—kidney—type 2 diabetes mellitus	0.00017	0.0124	CbGeAlD
Spironolactone—NR3C1—pancreas—type 2 diabetes mellitus	0.000169	0.0123	CbGeAlD
Spironolactone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000166	0.0121	CbGeAlD
Spironolactone—ABCC2—liver—type 2 diabetes mellitus	0.00016	0.0117	CbGeAlD
Spironolactone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000153	0.0112	CbGeAlD
Spironolactone—Drowsiness—Metformin—type 2 diabetes mellitus	0.000149	0.00206	CcSEcCtD
Spironolactone—AR—liver—type 2 diabetes mellitus	0.000149	0.0108	CbGeAlD
Spironolactone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000148	0.00203	CcSEcCtD
Spironolactone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000148	0.00203	CcSEcCtD
Spironolactone—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000147	0.00203	CcSEcCtD
Spironolactone—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000147	0.00202	CcSEcCtD
Spironolactone—Somnolence—Glipizide—type 2 diabetes mellitus	0.000147	0.00202	CcSEcCtD
Spironolactone—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000146	0.00202	CcSEcCtD
Spironolactone—Rash—Nateglinide—type 2 diabetes mellitus	0.000145	0.002	CcSEcCtD
Spironolactone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000145	0.002	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000142	0.00196	CcSEcCtD
Spironolactone—Nausea—Acarbose—type 2 diabetes mellitus	0.000142	0.00195	CcSEcCtD
Spironolactone—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000141	0.00194	CcSEcCtD
Spironolactone—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00193	CcSEcCtD
Spironolactone—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000139	0.00192	CcSEcCtD
Spironolactone—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000139	0.00191	CcSEcCtD
Spironolactone—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000137	0.00189	CcSEcCtD
Spironolactone—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000137	0.00188	CcSEcCtD
Spironolactone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000137	0.00188	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000136	0.00188	CcSEcCtD
Spironolactone—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00188	CcSEcCtD
Spironolactone—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000136	0.00188	CcSEcCtD
Spironolactone—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000136	0.00187	CcSEcCtD
Spironolactone—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000133	0.00183	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000133	0.00183	CcSEcCtD
Spironolactone—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000133	0.00183	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000133	0.00183	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00182	CcSEcCtD
Spironolactone—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000132	0.00181	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000132	0.00181	CcSEcCtD
Spironolactone—Urticaria—Glipizide—type 2 diabetes mellitus	0.000131	0.0018	CcSEcCtD
Spironolactone—Gastritis—Ramipril—type 2 diabetes mellitus	0.000131	0.0018	CcSEcCtD
Spironolactone—Renal failure—Losartan—type 2 diabetes mellitus	0.00013	0.0018	CcSEcCtD
Spironolactone—Alopecia—Valsartan—type 2 diabetes mellitus	0.00013	0.00179	CcSEcCtD
Spironolactone—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00013	0.00179	CcSEcCtD
Spironolactone—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00013	0.00178	CcSEcCtD
Spironolactone—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000129	0.00177	CcSEcCtD
Spironolactone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000129	0.00938	CbGeAlD
Spironolactone—Alopecia—Orlistat—type 2 diabetes mellitus	0.000129	0.00177	CcSEcCtD
Spironolactone—Confusional state—Glyburide—type 2 diabetes mellitus	0.000128	0.00176	CcSEcCtD
Spironolactone—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000127	0.00175	CcSEcCtD
Spironolactone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000127	0.00174	CcSEcCtD
Spironolactone—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000126	0.00174	CcSEcCtD
Spironolactone—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00174	CcSEcCtD
Spironolactone—Malaise—Gliclazide—type 2 diabetes mellitus	0.000126	0.00173	CcSEcCtD
Spironolactone—Rash—Repaglinide—type 2 diabetes mellitus	0.000126	0.00173	CcSEcCtD
Spironolactone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000126	0.00173	CcSEcCtD
Spironolactone—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000125	0.00173	CcSEcCtD
Spironolactone—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000125	0.00172	CcSEcCtD
Spironolactone—Headache—Repaglinide—type 2 diabetes mellitus	0.000125	0.00172	CcSEcCtD
Spironolactone—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000125	0.00171	CcSEcCtD
Spironolactone—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000124	0.00171	CcSEcCtD
Spironolactone—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000124	0.00171	CcSEcCtD
Spironolactone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000123	0.0017	CcSEcCtD
Spironolactone—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000123	0.0017	CcSEcCtD
Spironolactone—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000122	0.00168	CcSEcCtD
Spironolactone—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000122	0.00168	CcSEcCtD
Spironolactone—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000122	0.00168	CcSEcCtD
Spironolactone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000121	0.00167	CcSEcCtD
Spironolactone—CYP2C8—liver—type 2 diabetes mellitus	0.00012	0.00875	CbGeAlD
Spironolactone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00165	CcSEcCtD
Spironolactone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000119	0.00163	CcSEcCtD
Spironolactone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000119	0.00163	CcSEcCtD
Spironolactone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000118	0.00163	CcSEcCtD
Spironolactone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000118	0.00162	CcSEcCtD
Spironolactone—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.00162	CcSEcCtD
Spironolactone—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000118	0.00162	CcSEcCtD
Spironolactone—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000117	0.00162	CcSEcCtD
Spironolactone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000117	0.00161	CcSEcCtD
Spironolactone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000116	0.0016	CcSEcCtD
Spironolactone—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000115	0.00158	CcSEcCtD
Spironolactone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000114	0.00157	CcSEcCtD
Spironolactone—Malaise—Orlistat—type 2 diabetes mellitus	0.000114	0.00157	CcSEcCtD
Spironolactone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000113	0.00156	CcSEcCtD
Spironolactone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00156	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000113	0.00155	CcSEcCtD
Spironolactone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000113	0.00155	CcSEcCtD
Spironolactone—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000113	0.00155	CcSEcCtD
Spironolactone—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000112	0.00155	CcSEcCtD
Spironolactone—Renal failure—Ramipril—type 2 diabetes mellitus	0.000112	0.00154	CcSEcCtD
Spironolactone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000112	0.00154	CcSEcCtD
Spironolactone—Drospirenone—AR—type 2 diabetes mellitus	0.000112	0.0443	CrCbGaD
Spironolactone—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000112	0.00154	CcSEcCtD
Spironolactone—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00011	0.00152	CcSEcCtD
Spironolactone—ABCB1—retina—type 2 diabetes mellitus	0.00011	0.00802	CbGeAlD
Spironolactone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00011	0.00151	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00011	0.00151	CcSEcCtD
Spironolactone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000109	0.0015	CcSEcCtD
Spironolactone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000109	0.0015	CcSEcCtD
Spironolactone—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000108	0.00149	CcSEcCtD
Spironolactone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000108	0.00149	CcSEcCtD
Spironolactone—NR3C1—liver—type 2 diabetes mellitus	0.000108	0.00783	CbGeAlD
Spironolactone—Discomfort—Orlistat—type 2 diabetes mellitus	0.000107	0.00147	CcSEcCtD
Spironolactone—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000106	0.00146	CcSEcCtD
Spironolactone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000106	0.00146	CcSEcCtD
Spironolactone—Malaise—Metformin—type 2 diabetes mellitus	0.000105	0.00145	CcSEcCtD
Spironolactone—Alopecia—Losartan—type 2 diabetes mellitus	0.000105	0.00145	CcSEcCtD
Spironolactone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000105	0.00145	CcSEcCtD
Spironolactone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000105	0.0417	CrCbGaD
Spironolactone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000105	0.00144	CcSEcCtD
Spironolactone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000105	0.00144	CcSEcCtD
Spironolactone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000105	0.00144	CcSEcCtD
Spironolactone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000105	0.00144	CcSEcCtD
Spironolactone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000104	0.00144	CcSEcCtD
Spironolactone—Rash—Glipizide—type 2 diabetes mellitus	0.000104	0.00143	CcSEcCtD
Spironolactone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000104	0.00143	CcSEcCtD
Spironolactone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000104	0.00755	CbGeAlD
Spironolactone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000103	0.00142	CcSEcCtD
Spironolactone—Headache—Glipizide—type 2 diabetes mellitus	0.000103	0.00142	CcSEcCtD
Spironolactone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000103	0.00141	CcSEcCtD
Spironolactone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000102	0.00141	CcSEcCtD
Spironolactone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000102	0.0014	CcSEcCtD
Spironolactone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000101	0.0014	CcSEcCtD
Spironolactone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000101	0.00139	CcSEcCtD
Spironolactone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000101	0.00139	CcSEcCtD
Spironolactone—Muscle spasms—Losartan—type 2 diabetes mellitus	9.97e-05	0.00137	CcSEcCtD
Spironolactone—Malaise—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.00137	CcSEcCtD
Spironolactone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	9.91e-05	0.0393	CrCbGaD
Spironolactone—Headache—Pioglitazone—type 2 diabetes mellitus	9.9e-05	0.00136	CcSEcCtD
Spironolactone—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.00136	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.00135	CcSEcCtD
Spironolactone—Discomfort—Metformin—type 2 diabetes mellitus	9.83e-05	0.00135	CcSEcCtD
Spironolactone—Nausea—Glipizide—type 2 diabetes mellitus	9.79e-05	0.00135	CcSEcCtD
Spironolactone—Vomiting—Glimepiride—type 2 diabetes mellitus	9.78e-05	0.00135	CcSEcCtD
Spironolactone—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.75e-05	0.00134	CcSEcCtD
Spironolactone—Rash—Glimepiride—type 2 diabetes mellitus	9.7e-05	0.00134	CcSEcCtD
Spironolactone—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.69e-05	0.00133	CcSEcCtD
Spironolactone—Rash—Sitagliptin—type 2 diabetes mellitus	9.67e-05	0.00133	CcSEcCtD
Spironolactone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.66e-05	0.00133	CcSEcCtD
Spironolactone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	9.66e-05	0.00133	CcSEcCtD
Spironolactone—Headache—Glimepiride—type 2 diabetes mellitus	9.64e-05	0.00133	CcSEcCtD
Spironolactone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.63e-05	0.00132	CcSEcCtD
Spironolactone—Headache—Sitagliptin—type 2 diabetes mellitus	9.61e-05	0.00132	CcSEcCtD
Spironolactone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.5e-05	0.00131	CcSEcCtD
Spironolactone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.39e-05	0.00129	CcSEcCtD
Spironolactone—Testosterone Propionate—AR—type 2 diabetes mellitus	9.37e-05	0.0372	CrCbGaD
Spironolactone—Malaise—Losartan—type 2 diabetes mellitus	9.36e-05	0.00129	CcSEcCtD
Spironolactone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.35e-05	0.00129	CcSEcCtD
Spironolactone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.33e-05	0.00128	CcSEcCtD
Spironolactone—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.32e-05	0.00678	CbGeAlD
Spironolactone—Somnolence—Valsartan—type 2 diabetes mellitus	9.31e-05	0.00128	CcSEcCtD
Spironolactone—Leukopenia—Losartan—type 2 diabetes mellitus	9.29e-05	0.00128	CcSEcCtD
Spironolactone—Discomfort—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.00128	CcSEcCtD
Spironolactone—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.18e-05	0.00126	CcSEcCtD
Spironolactone—Hydrocortamate—NR3C1—type 2 diabetes mellitus	9.14e-05	0.0363	CrCbGaD
Spironolactone—Nausea—Glimepiride—type 2 diabetes mellitus	9.14e-05	0.00126	CcSEcCtD
Spironolactone—ABCB1—kidney—type 2 diabetes mellitus	9.12e-05	0.00663	CbGeAlD
Spironolactone—Nausea—Sitagliptin—type 2 diabetes mellitus	9.11e-05	0.00125	CcSEcCtD
Spironolactone—ABCB1—pancreas—type 2 diabetes mellitus	9.06e-05	0.00659	CbGeAlD
Spironolactone—Urticaria—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.00125	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.04e-05	0.00124	CcSEcCtD
Spironolactone—Alopecia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.00124	CcSEcCtD
Spironolactone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.01e-05	0.00124	CcSEcCtD
Spironolactone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	9e-05	0.0357	CrCbGaD
Spironolactone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9e-05	0.00124	CcSEcCtD
Spironolactone—Pruritus—Glyburide—type 2 diabetes mellitus	8.98e-05	0.00124	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.93e-05	0.00123	CcSEcCtD
Spironolactone—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.88e-05	0.00646	CbGeAlD
Spironolactone—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.83e-05	0.00121	CcSEcCtD
Spironolactone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.00121	CcSEcCtD
Spironolactone—Rash—Bromocriptine—type 2 diabetes mellitus	8.75e-05	0.0012	CcSEcCtD
Spironolactone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.74e-05	0.0012	CcSEcCtD
Spironolactone—Discomfort—Losartan—type 2 diabetes mellitus	8.73e-05	0.0012	CcSEcCtD
Spironolactone—Headache—Bromocriptine—type 2 diabetes mellitus	8.7e-05	0.0012	CcSEcCtD
Spironolactone—Fluoxymesterone—AR—type 2 diabetes mellitus	8.69e-05	0.0345	CrCbGaD
Spironolactone—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.68e-05	0.0012	CcSEcCtD
Spironolactone—Megestrol acetate—NR3C1—type 2 diabetes mellitus	8.68e-05	0.0344	CrCbGaD
Spironolactone—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.55e-05	0.00118	CcSEcCtD
Spironolactone—Confusional state—Losartan—type 2 diabetes mellitus	8.54e-05	0.00118	CcSEcCtD
Spironolactone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.52e-05	0.00117	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	8.5e-05	0.0337	CrCbGaD
Spironolactone—Somnolence—Metformin—type 2 diabetes mellitus	8.48e-05	0.00117	CcSEcCtD
Spironolactone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.47e-05	0.00117	CcSEcCtD
Spironolactone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.00116	CcSEcCtD
Spironolactone—Urticaria—Valsartan—type 2 diabetes mellitus	8.32e-05	0.00114	CcSEcCtD
Spironolactone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.29e-05	0.00114	CcSEcCtD
Spironolactone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.25e-05	0.00114	CcSEcCtD
Spironolactone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.25e-05	0.00113	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.23e-05	0.00113	CcSEcCtD
Spironolactone—Urticaria—Orlistat—type 2 diabetes mellitus	8.22e-05	0.00113	CcSEcCtD
Spironolactone—ABCB1—adipose tissue—type 2 diabetes mellitus	8.22e-05	0.00598	CbGeAlD
Spironolactone—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.18e-05	0.00113	CcSEcCtD
Spironolactone—Vomiting—Glyburide—type 2 diabetes mellitus	8.07e-05	0.00111	CcSEcCtD
Spironolactone—Pruritus—Gliclazide—type 2 diabetes mellitus	8.06e-05	0.00111	CcSEcCtD
Spironolactone—Malaise—Ramipril—type 2 diabetes mellitus	8.02e-05	0.0011	CcSEcCtD
Spironolactone—Rash—Glyburide—type 2 diabetes mellitus	8e-05	0.0011	CcSEcCtD
Spironolactone—Methyltestosterone—SHBG—type 2 diabetes mellitus	8e-05	0.0317	CrCbGaD
Spironolactone—Somnolence—Irbesartan—type 2 diabetes mellitus	8e-05	0.0011	CcSEcCtD
Spironolactone—Dermatitis—Glyburide—type 2 diabetes mellitus	7.99e-05	0.0011	CcSEcCtD
Spironolactone—Leukopenia—Ramipril—type 2 diabetes mellitus	7.96e-05	0.0011	CcSEcCtD
Spironolactone—Headache—Glyburide—type 2 diabetes mellitus	7.95e-05	0.00109	CcSEcCtD
Spironolactone—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.86e-05	0.00108	CcSEcCtD
Spironolactone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.8e-05	0.00107	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.00107	CcSEcCtD
Spironolactone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.71e-05	0.00106	CcSEcCtD
Spironolactone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.62e-05	0.00105	CcSEcCtD
Spironolactone—Urticaria—Metformin—type 2 diabetes mellitus	7.57e-05	0.00104	CcSEcCtD
Spironolactone—Nausea—Glyburide—type 2 diabetes mellitus	7.54e-05	0.00104	CcSEcCtD
Spironolactone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.00104	CcSEcCtD
Spironolactone—Somnolence—Losartan—type 2 diabetes mellitus	7.53e-05	0.00104	CcSEcCtD
Spironolactone—Discomfort—Ramipril—type 2 diabetes mellitus	7.48e-05	0.00103	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	7.45e-05	0.0296	CrCbGaD
Spironolactone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.00102	CcSEcCtD
Spironolactone—Pruritus—Valsartan—type 2 diabetes mellitus	7.41e-05	0.00102	CcSEcCtD
Spironolactone—Confusional state—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00101	CcSEcCtD
Spironolactone—Pruritus—Orlistat—type 2 diabetes mellitus	7.32e-05	0.00101	CcSEcCtD
Spironolactone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000999	CcSEcCtD
Spironolactone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000997	CcSEcCtD
Spironolactone—Rash—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000989	CcSEcCtD
Spironolactone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000988	CcSEcCtD
Spironolactone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.16e-05	0.000986	CcSEcCtD
Spironolactone—Urticaria—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000984	CcSEcCtD
Spironolactone—Headache—Gliclazide—type 2 diabetes mellitus	7.14e-05	0.000983	CcSEcCtD
Spironolactone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	7.13e-05	0.0283	CrCbGaD
Spironolactone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000979	CcSEcCtD
Spironolactone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000978	CcSEcCtD
Spironolactone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.08e-05	0.000974	CcSEcCtD
Spironolactone—Methyltestosterone—AR—type 2 diabetes mellitus	7.01e-05	0.0278	CrCbGaD
Spironolactone—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.98e-05	0.00096	CcSEcCtD
Spironolactone—Dizziness—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000953	CcSEcCtD
Spironolactone—Dizziness—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000942	CcSEcCtD
Spironolactone—Nausea—Gliclazide—type 2 diabetes mellitus	6.77e-05	0.000932	CcSEcCtD
Spironolactone—Pruritus—Metformin—type 2 diabetes mellitus	6.74e-05	0.000928	CcSEcCtD
Spironolactone—Urticaria—Losartan—type 2 diabetes mellitus	6.73e-05	0.000926	CcSEcCtD
Spironolactone—Body temperature increased—Losartan—type 2 diabetes mellitus	6.69e-05	0.000921	CcSEcCtD
Spironolactone—Vomiting—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000916	CcSEcCtD
Spironolactone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000912	CcSEcCtD
Spironolactone—Rash—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000909	CcSEcCtD
Spironolactone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.59e-05	0.000908	CcSEcCtD
Spironolactone—Testosterone—CYP11A1—type 2 diabetes mellitus	6.59e-05	0.0261	CrCbGaD
Spironolactone—Vomiting—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000905	CcSEcCtD
Spironolactone—Headache—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000903	CcSEcCtD
Spironolactone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.52e-05	0.000898	CcSEcCtD
Spironolactone—Rash—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000898	CcSEcCtD
Spironolactone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000897	CcSEcCtD
Spironolactone—Headache—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000892	CcSEcCtD
Spironolactone—Somnolence—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000888	CcSEcCtD
Spironolactone—Pruritus—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000876	CcSEcCtD
Spironolactone—Dizziness—Metformin—type 2 diabetes mellitus	6.3e-05	0.000868	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000863	CcSEcCtD
Spironolactone—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.24e-05	0.000859	CcSEcCtD
Spironolactone—Nausea—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000856	CcSEcCtD
Spironolactone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000847	CcSEcCtD
Spironolactone—Nausea—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000846	CcSEcCtD
Spironolactone—Vomiting—Metformin—type 2 diabetes mellitus	6.06e-05	0.000834	CcSEcCtD
Spironolactone—Hydrocortisone—SHBG—type 2 diabetes mellitus	6.02e-05	0.0239	CrCbGaD
Spironolactone—Rash—Metformin—type 2 diabetes mellitus	6.01e-05	0.000827	CcSEcCtD
Spironolactone—Dermatitis—Metformin—type 2 diabetes mellitus	6.01e-05	0.000827	CcSEcCtD
Spironolactone—Pruritus—Losartan—type 2 diabetes mellitus	5.99e-05	0.000824	CcSEcCtD
Spironolactone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000823	CcSEcCtD
Spironolactone—Headache—Metformin—type 2 diabetes mellitus	5.97e-05	0.000822	CcSEcCtD
Spironolactone—Dizziness—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000819	CcSEcCtD
Spironolactone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	5.89e-05	0.0234	CrCbGaD
Spironolactone—Diarrhoea—Losartan—type 2 diabetes mellitus	5.79e-05	0.000797	CcSEcCtD
Spironolactone—Urticaria—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000794	CcSEcCtD
Spironolactone—ABCB1—liver—type 2 diabetes mellitus	5.76e-05	0.00419	CbGeAlD
Spironolactone—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.74e-05	0.00079	CcSEcCtD
Spironolactone—Vomiting—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000787	CcSEcCtD
Spironolactone—Rash—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000781	CcSEcCtD
Spironolactone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.00078	CcSEcCtD
Spironolactone—Nausea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000779	CcSEcCtD
Spironolactone—Headache—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000776	CcSEcCtD
Spironolactone—Dizziness—Losartan—type 2 diabetes mellitus	5.6e-05	0.000771	CcSEcCtD
Spironolactone—Vomiting—Losartan—type 2 diabetes mellitus	5.38e-05	0.000741	CcSEcCtD
Spironolactone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000736	CcSEcCtD
Spironolactone—Nausea—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000736	CcSEcCtD
Spironolactone—Rash—Losartan—type 2 diabetes mellitus	5.34e-05	0.000735	CcSEcCtD
Spironolactone—Dermatitis—Losartan—type 2 diabetes mellitus	5.33e-05	0.000734	CcSEcCtD
Spironolactone—Headache—Losartan—type 2 diabetes mellitus	5.3e-05	0.00073	CcSEcCtD
Spironolactone—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	5.3e-05	0.021	CrCbGaD
Spironolactone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	5.22e-05	0.0207	CrCbGaD
Spironolactone—Pruritus—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000707	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	5.05e-05	0.0201	CrCbGaD
Spironolactone—Nausea—Losartan—type 2 diabetes mellitus	5.03e-05	0.000692	CcSEcCtD
Spironolactone—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000684	CcSEcCtD
Spironolactone—Progesterone—SHBG—type 2 diabetes mellitus	4.91e-05	0.0195	CrCbGaD
Spironolactone—Dizziness—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000661	CcSEcCtD
Spironolactone—Testosterone—SHBG—type 2 diabetes mellitus	4.64e-05	0.0184	CrCbGaD
Spironolactone—Vomiting—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000635	CcSEcCtD
Spironolactone—Eplerenone—CYP3A4—type 2 diabetes mellitus	4.58e-05	0.0182	CrCbGaD
Spironolactone—Rash—Ramipril—type 2 diabetes mellitus	4.58e-05	0.00063	CcSEcCtD
Spironolactone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000629	CcSEcCtD
Spironolactone—Headache—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000626	CcSEcCtD
Spironolactone—Nausea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000594	CcSEcCtD
Spironolactone—Progesterone—AR—type 2 diabetes mellitus	4.3e-05	0.0171	CrCbGaD
Spironolactone—Drospirenone—PTGS2—type 2 diabetes mellitus	4.3e-05	0.0171	CrCbGaD
Spironolactone—Testosterone—AR—type 2 diabetes mellitus	4.07e-05	0.0161	CrCbGaD
Spironolactone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	3.58e-05	0.0142	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	2.93e-05	0.0116	CrCbGaD
Spironolactone—Progesterone—NR3C1—type 2 diabetes mellitus	2.92e-05	0.0116	CrCbGaD
Spironolactone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	2.76e-05	0.0109	CrCbGaD
Spironolactone—Progesterone—CYP1A2—type 2 diabetes mellitus	2.56e-05	0.0101	CrCbGaD
Spironolactone—Methyltestosterone—ALB—type 2 diabetes mellitus	2.41e-05	0.00955	CrCbGaD
Spironolactone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.08e-05	0.00824	CrCbGaD
Spironolactone—Progesterone—CYP3A4—type 2 diabetes mellitus	1.69e-05	0.00672	CrCbGaD
Spironolactone—Testosterone—CYP3A4—type 2 diabetes mellitus	1.6e-05	0.00635	CrCbGaD
Spironolactone—Testosterone—ALB—type 2 diabetes mellitus	1.4e-05	0.00554	CrCbGaD
Spironolactone—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.94e-06	9.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.94e-06	9.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	4.89e-06	9.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	4.89e-06	9.22e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AVP—type 2 diabetes mellitus	4.87e-06	9.19e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.87e-06	9.19e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.85e-06	9.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.83e-06	9.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—COX2—type 2 diabetes mellitus	4.82e-06	9.08e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A2—type 2 diabetes mellitus	4.82e-06	9.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	4.79e-06	9.03e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.77e-06	8.99e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—type 2 diabetes mellitus	4.74e-06	8.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.74e-06	8.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA6—type 2 diabetes mellitus	4.73e-06	8.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.73e-06	8.92e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOB—type 2 diabetes mellitus	4.71e-06	8.88e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.69e-06	8.85e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	4.66e-06	8.79e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARA—type 2 diabetes mellitus	4.65e-06	8.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD11B1—type 2 diabetes mellitus	4.65e-06	8.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UCP2—type 2 diabetes mellitus	4.65e-06	8.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UCP3—type 2 diabetes mellitus	4.65e-06	8.77e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.64e-06	8.74e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SERPINE1—type 2 diabetes mellitus	4.55e-06	8.58e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	4.55e-06	8.58e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.55e-06	8.58e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	4.55e-06	8.58e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.54e-06	8.57e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—type 2 diabetes mellitus	4.54e-06	8.57e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—type 2 diabetes mellitus	4.53e-06	8.55e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.53e-06	8.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.51e-06	8.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LPL—type 2 diabetes mellitus	4.5e-06	8.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.48e-06	8.45e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—INS—type 2 diabetes mellitus	4.46e-06	8.4e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.4e-06	8.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PCK1—type 2 diabetes mellitus	4.37e-06	8.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	4.36e-06	8.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	4.36e-06	8.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.3e-06	8.12e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.29e-06	8.1e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.29e-06	8.08e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.29e-06	8.08e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.27e-06	8.05e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	4.25e-06	8.01e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.22e-06	7.96e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAT—type 2 diabetes mellitus	4.21e-06	7.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.2e-06	7.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	4.2e-06	7.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.2e-06	7.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	4.17e-06	7.87e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—type 2 diabetes mellitus	4.15e-06	7.82e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.14e-06	7.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	4.12e-06	7.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	4.09e-06	7.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	4.09e-06	7.72e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOB—type 2 diabetes mellitus	4.09e-06	7.71e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—type 2 diabetes mellitus	4.08e-06	7.71e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.06e-06	7.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.05e-06	7.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	4.05e-06	7.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	4.05e-06	7.64e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	4.05e-06	7.64e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.97e-06	7.5e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	3.95e-06	7.46e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	3.95e-06	7.46e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	3.95e-06	7.46e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	3.95e-06	7.46e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.92e-06	7.39e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—type 2 diabetes mellitus	3.91e-06	7.37e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.91e-06	7.37e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LPL—type 2 diabetes mellitus	3.9e-06	7.36e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.9e-06	7.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.86e-06	7.29e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.86e-06	7.28e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.85e-06	7.27e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—type 2 diabetes mellitus	3.85e-06	7.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	3.85e-06	7.26e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.82e-06	7.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	3.81e-06	7.19e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.81e-06	7.18e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.8e-06	7.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	3.79e-06	7.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.78e-06	7.14e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	3.77e-06	7.11e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	3.77e-06	7.11e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.75e-06	7.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.73e-06	7.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.73e-06	7.03e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.73e-06	7.03e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD36—type 2 diabetes mellitus	3.71e-06	6.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.68e-06	6.95e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.66e-06	6.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.66e-06	6.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.61e-06	6.81e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—type 2 diabetes mellitus	3.57e-06	6.74e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	3.57e-06	6.73e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.57e-06	6.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.55e-06	6.71e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	3.53e-06	6.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	3.52e-06	6.65e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.51e-06	6.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.49e-06	6.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.48e-06	6.57e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.47e-06	6.54e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.45e-06	6.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.45e-06	6.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	3.45e-06	6.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.45e-06	6.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	3.45e-06	6.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.36e-06	6.34e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	3.34e-06	6.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	3.3e-06	6.23e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	3.29e-06	6.21e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.28e-06	6.19e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—type 2 diabetes mellitus	3.28e-06	6.18e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	3.27e-06	6.17e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.23e-06	6.1e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	3.22e-06	6.08e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	3.22e-06	6.08e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	3.22e-06	6.08e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.17e-06	5.98e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	3.16e-06	5.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.15e-06	5.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.14e-06	5.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	3.14e-06	5.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	3.14e-06	5.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	3.14e-06	5.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	3.12e-06	5.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.11e-06	5.88e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.11e-06	5.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	3.07e-06	5.79e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	3.07e-06	5.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	3.03e-06	5.72e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.96e-06	5.58e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.95e-06	5.57e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	2.92e-06	5.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.87e-06	5.41e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.85e-06	5.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.83e-06	5.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.82e-06	5.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.82e-06	5.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	2.82e-06	5.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	2.82e-06	5.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	2.82e-06	5.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.81e-06	5.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.81e-06	5.3e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	2.79e-06	5.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	2.77e-06	5.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.75e-06	5.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	2.74e-06	5.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.74e-06	5.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.74e-06	5.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.74e-06	5.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.72e-06	5.13e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.7e-06	5.1e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	2.68e-06	5.06e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.67e-06	5.04e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.66e-06	5.01e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.64e-06	4.98e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.63e-06	4.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.59e-06	4.89e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	2.58e-06	4.86e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	2.56e-06	4.83e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	2.55e-06	4.81e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	2.55e-06	4.81e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	2.48e-06	4.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.47e-06	4.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.45e-06	4.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.45e-06	4.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.45e-06	4.63e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.45e-06	4.62e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.45e-06	4.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	2.44e-06	4.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	2.44e-06	4.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.41e-06	4.55e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.4e-06	4.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.39e-06	4.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.34e-06	4.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.34e-06	4.41e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.27e-06	4.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.25e-06	4.24e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.24e-06	4.23e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.24e-06	4.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.22e-06	4.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.22e-06	4.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.16e-06	4.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.13e-06	4.02e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.13e-06	4.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.11e-06	3.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.11e-06	3.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.1e-06	3.95e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.09e-06	3.94e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	3.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.07e-06	3.9e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.03e-06	3.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.01e-06	3.79e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	2e-06	3.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.95e-06	3.68e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.92e-06	3.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.88e-06	3.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-06	3.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.87e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.83e-06	3.46e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.83e-06	3.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.83e-06	3.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-06	3.44e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.82e-06	3.44e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.8e-06	3.4e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.8e-06	3.39e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—type 2 diabetes mellitus	1.8e-06	3.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.75e-06	3.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.73e-06	3.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.7e-06	3.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.69e-06	3.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.67e-06	3.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.64e-06	3.09e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-06	3.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.63e-06	3.07e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-06	3.04e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.61e-06	3.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-06	3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.59e-06	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	2.96e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—type 2 diabetes mellitus	1.52e-06	2.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.5e-06	2.84e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-06	2.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	2.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.41e-06	2.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.4e-06	2.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	2.64e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	2.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.38e-06	2.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.37e-06	2.59e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.3e-06	2.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	2.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	2.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	2.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	2.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.2e-06	2.26e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	1.15e-06	2.18e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.13e-06	2.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	2.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	2.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	1.98e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	1.98e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	9.59e-07	1.81e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	5.53e-07	1.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.82e-07	9.09e-06	CbGpPWpGaD
